One-year worsening heart failure and myocardial T1 mapping in patients with wild-type transthyretin amyloid cardiomyopathy undergoing tafamidis treatment

Background: There is a paucity of data regarding short-term outcomes and treatment responsiveness of myocardial T1 mapping via cardiac magnetic resonance (CMR) in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) undergoing tafamidis therapy. Methods: We retrospectively studied 60 wild-ty...

Description complète

Détails bibliographiques

Auteurs principaux:	Toshiro Kitagawa, Kotaro Hamamoto, Daiki Okamoto, Yuki Ikegami, Yoshiharu Sada, Fuminari Tatsugami, Yukiko Nakano
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2026-06-01
Collection:	International Journal of Cardiology: Heart & Vasculature
Sujets:	Heart failure Tafamidis Transthyretin amyloid cardiomyopathy T1 mapping
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2352906726000680
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!